HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nakajima, H. Articles by Miller, J. S. Search for Related Content PubMed PubMed Citation Articles by Nakajima, H. Articles by Miller, J. S.

The BCR/ABL Transgene Causes Abnormal NK Cell Differentiation and Can Be Found in Circulating NK Cells of Advanced Phase Chronic Myelogenous Leukemia Patients¹

Hikaru Nakajima^*, Robert Zhao^*, Troy C. Lund^*, Jeanne Ward^*, Michelle Dolan, Betsy Hirsch and Jeffrey S. Miller^2,*

Departments of ^* Medicine and Laboratory Medicine and Pathology, University of Minnesota Cancer Center, Minneapolis, MN 55455

NK cells from the blood of chronic myelogenous leukemia (CML) patients are progressively decreased in number as the disease progresses from chronic phase to blast crisis. We hypothesize that BCR/ABL may be directly responsible by interfering with NK cell differentiation. CD34⁺HLA-DR⁺ cells from CML patients were studied for their capacity to differentiate into NK cells. The NK cell cloning frequency was significantly decreased from CML CD34⁺HLA-DR⁺ cells compared with cells from normal donors, yet CD34⁺HLA-DR⁺ cells gave rise to BCR/ABL⁺ NK cells in some patients. This finding prompted us to further investigate circulating NK cells from the blood of CML patients. CD56⁺CD3^- NK cells were sorted from CML patients and examined by fluorescence in situ hybridization (FISH). In contrast to chronic phase CML, significant numbers of NK cells from advanced phase CML patients were BCR/ABL⁺, whereas T cells were always BCR/ABL^- regardless of the disease stage. To test the effects of BCR/ABL as the sole genetic abnormality, BCR/ABL was transduced into umbilical cord blood CD34⁺ cells, and NK development was studied. p210-enhanced green fluorescence protein-transduced cells gave rise to significantly decreased numbers of NK cells compared with enhanced green fluorescence protein transduction alone. In addition, the extrinsic addition of BCR/ABL-transduced autologous CD34⁺ cells suppressed the NK cell differentiation of normal umbilical cord blood CD34⁺CD38^- cells. This study provides the first evidence that BCR/ABL is responsible for the altered differentiation of NK cells and that the NK cell lineage can be involved with the malignant clone in advanced stage CML.

This article has been cited by other articles:

				D. H. Kim, S. Kamel-Reid, H. Chang, R. Sutherland, C. W. Jung, H.-J. Kim, J.-J. Lee, and J. H. Lipton Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia Haematologica, January 1, 2009; 94(1): 135 - 139. [Abstract] [Full Text] [PDF]

				M. Terme, C. Borg, F. Guilhot, C. Masurier, C. Flament, E. F. Wagner, S. Caillat-Zucman, A. Bernheim, A. G. Turhan, A. Caignard, et al. BCR/ABL Promotes Dendritic Cell-Mediated Natural Killer Cell Activation Cancer Res., July 15, 2005; 65(14): 6409 - 6417. [Abstract] [Full Text] [PDF]

				E. G. Chiorean, S. J. Dylla, K. Olsen, T. Lenvik, Y. Soignier, and J. S. Miller BCR/ABL alters the function of NK cells and the acquisition of killer immunoglobulin-like receptors (KIRs) Blood, May 1, 2003; 101(9): 3527 - 3533. [Abstract] [Full Text] [PDF]